Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

794.77
+0.58000.07%
Volume:96.39K
Turnover:75.93M
Market Cap:81.83B
PE:19.66
High:795.61
Open:782.44
Low:779.08
Close:794.19
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.56
T/O Rate:0.10%
Dividend:3.64
Dividend Rate:0.46%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.58
PE(LYR):19.16

Loading ...

Regeneron Q2 FY26 GAAP EPS Falls 5% to $12.23; Revenue Rises 17% to $4.3 Billion

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 4.25% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Q2 Adj. EPS $14.29 Beats $10.26 Estimate, Sales $4.291B Beat $3.816B Estimate

Benzinga Earnings
·
Jul 30

Regeneron Pharmaceuticals - Q2 Eylea Hd U.S. Net Sales up 52% to $596 Mln

THOMSON REUTERS
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 VS. Ibes Estimate USD 10.3

THOMSON REUTERS
·
Jul 30

Regeneron Outlook FY Capex USD 1,030-1,100 Million

THOMSON REUTERS
·
Jul 30

Regeneron Pharmaceuticals - Q2 Dupixent Global Net Sales Rise 38% to $6 Bln

THOMSON REUTERS
·
Jul 30

Sanofi Drug Pipeline Worries, Dupixent Dependence Shake Shares

Reuters
·
Jul 30

Regeneron Pharmaceuticals Lawsuit Alleges Investors Were Misled Before REGN Stock Drops

TIPRANKS
·
Jul 29

Movement Alert|Regeneron Pharmaceuticals Rises 3.05% in Regular Trading, Biotech Sector Rallies Broadly Ahead of Q2 Earnings

Market Focus
·
Jul 28

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Movement Alert|Regeneron Pharmaceuticals Rises 3.08% in Regular Trading, Trading at $676.44

Market Focus
·
Jul 27

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Reuters
·
Jul 27

Telix-Regeneron Radiopharma Deal and Lawsuit Could Be A Game Changer For Regeneron Pharmaceuticals (REGN)

Simply Wall St.
·
Jul 27

The Scientist with 1,000 Patents Fueling a Drug Powerhouse

Dow Jones
·
Jul 25

Earning Preview: Regeneron Pharmaceuticals—this quarter’s revenue is expected to increase by 16.16%, and institutional views are predominantly bullish

Earnings Agent
·
Jul 24

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Movement Alert|Regeneron Pharmaceuticals Falls 3.28% in Regular Trading, Multiple Investment Banks Cut Target Prices Amid Earnings Warning

Market Focus
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Regeneron (REGN) Receives a Buy from Goldman Sachs

TIPRANKS
·
Jul 22